Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Mark W. Bellomy has joined the firm’s technology transactions practice as a partner in the Boston office, where he will focus on representing life sciences clients. The addition reflects the continuing growth of Wilson Sonsini’s Boston office and rising demand for life sciences experience. Most recently, Bellomy was a partner in the IP transactions and life sciences groups in the Boston office of Ropes & Gray.
A 20-year veteran of the Boston life sciences ecosystem, Bellomy has advised public and private companies, investors, and institutions on pivotal transactions involving technology and intellectual property, including research, development, and commercialization collaboration and licensing arrangements; joint ventures; mergers and acquisitions; co-promotion relationships; and other strategic transactions.
Bellomy has extensive experience representing companies in the life sciences, pharmaceutical, biotechnology, digital health, healthcare, medical technology, private equity, investment, and branded product industries. In addition, he is a member of the Patent Bar and advises clients on strategic issues related to the creation, management, protection, and value generation of IP assets.
“Heightened business activity among companies and investors in many life sciences sectors—due in part to efforts aimed at battling the pandemic—has increased demand among our clients for deal-making expertise, particularly R&D agreements, collaborations, and other sophisticated transactions,” said Doug Clark, managing partner at Wilson Sonsini. “Mark’s 20-plus years of experience representing life sciences clients in all types of deals will be of great value to companies, investors, and institutions in the industry. We know he’ll make important and enduring contributions to the work of our clients, including those in the biopharmaceutical and medtech sectors.”
Bellomy started his legal career as an associate there in 2000 before leaving briefly to become senior licensing counsel for Wyeth Pharmaceuticals in 2007. He then rejoined Ropes & Gray, where he was promoted to partner in 2010. Prior to attending law school, Bellomy served as an officer in the U.S. Army.
Bellomy received his J.D., magna cum laude, from Harvard Law School in 2000 and a B.S. in electrical engineering from the United States Military Academy at West Point in 1994. He is admitted to practice in Massachusetts and before the U.S. Patent and Trademark Office.
Wilson Sonsini opened its Boston office in 2016 to better integrate into and service clients in one of the top life sciences markets in the U.S. and the world. The office recently celebrated its fifth anniversary and now has 35 attorneys and seven patent agents who represent clients primarily in the life sciences industry. Many of the firm’s Boston-based attorneys and other professionals have substantial life sciences expertise and experience, having earned advanced scientific degrees and/or represented pharmaceutical, biotechnology, medical device, and diagnostic companies. They regularly work with clients doing business in cutting-edge scientific arenas, including cell therapy, gene editing/CRISPR, digital health, and immunotherapeutics.
“Mark’s addition is another example of Wilson Sonsini’s growing presence in Boston and it underscores the firm’s commitment to growing its East Coast offices and expanding its life sciences transactions practice,” said Ian Edvalson, co-head of Wilson Sonsini’s technology transactions practice and a member of the firm’s board of directors.
Source: www.wsgr.com
